+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 90Years
All Genders
ID06169163

Breath Test Using Volatile Organic Compounds to Detect Squamous Oesophageal Cancer

Led by Imperial College London · Updated on 2025-05-02

518

Participants Needed

13

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Oesophageal Squamous Cell Carcinoma OSCC is a type of cancer affecting the food pipe, with poor survival rates when detected late. Early detection greatly improves survival, but current methods like endoscopy are invasive and uncomfortable. Researchers are evaluating a breath test that detects volatile organic compounds produced by the cancer, aiming to offer a non-invasive, simple, and cost-effective way to identify OSCC early in patients with non-specific symptoms. This study involves two groups one with patients newly diagnosed with OSCC who have not yet received treatment, and a control group undergoing endoscopy for upper gastrointestinal symptoms but without cancer. Participants will provide breath samples by exhaling into single-use collection bags twice, with the samples then analyzed at a laboratory to identify cancer-related compounds. Room air samples will also be collected for comparison. Participants will be asked to provide breath samples after maintaining a clear fluid diet for at least six hours. The study will measure the accuracy of the breath test in detecting OSCC and assess factors that might affect the test results. The total study duration for outcome measurement is 36 months, supported by multiple centers and led by Imperial College London.

CONDITIONS

Brief Title

Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

Research Team

S

Sameera Sharma, MBBS; MRCS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here